"
Team:LIKA-CESAR-Brasil/Biobricks
From 2014.igem.org
(Difference between revisions)
Villaverde (Talk | contribs) |
Villaverde (Talk | contribs) |
||
| Line 71: | Line 71: | ||
<li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/Safety">SAFETY</a></li> | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/Safety">SAFETY</a></li> | ||
<li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/Atribuitons">ATRIBUITIONS</a></li> | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/Atribuitons">ATRIBUITIONS</a></li> | ||
| + | <li class="igem-logo"><a href="https://2014.igem.org/"></a></li> | ||
</ul> | </ul> | ||
</div><!--/.nav-collapse --> | </div><!--/.nav-collapse --> | ||
Revision as of 22:52, 17 October 2014
PARTS
Biobricks
The team produced three new biobricks to the registry, three composite indication for cell lysis. The biobrick number BBa_K1565002 is the favorite team.
